Pan, Zeyan
Di, Shengmeng
Shi, Bizhi
Jiang, Hua
Shi, Zhimin
Liu, Ying
Wang, Yi
Luo, Hong
Yu, Min
Wu, Xiuqi
Li, Zonghai
Funding for this research was provided by:
Shanghai Science and Technology Innovation Action Plan (No. 16DZ1910700)
Collaborative Innovation Center for Translational Medicine at Shanghai Jiao Tong University School of Medicine (TM201601)
Research Fund of Shanghai Municipal Commission of Health and Family Planning (NO. 20174Y0178)
the National Natural Science Foundation of China (81472569)
the “13th Five-Year Plan” National Science and Technology Major Project of China (2017ZX10203206006)
Article History
Received: 26 November 2017
Accepted: 27 July 2018
First Online: 4 August 2018
Compliance with ethical standards
:
: Dr. Zonghai Li has ownership interests regarding GPC3-specific CAR-T cells with sPD1 coexpression. The other authors declare no conflict of interest.
: The study was approved by the Shanghai Science and Technology Committee, approval number: SYXK (SH) 2017-0011. The protocols followed the appropriate guidelines and were approved by the Shanghai Medical Experimental Animal Care Commission.
: The peripheral blood mononuclear cells (PBMCs) from healthy donors were obtained by the Shanghai Blood Center from staff members of the research laboratory who volunteered to donate blood. They consented to the use of this blood for research purposes.